Palisade Bio is Granted Fast Track Designation from the

Carlsbad, CA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies...

Related Keywords

,Jenene Thomas ,Herbertb Slade ,Exchange Commission ,Company Annual Report On Form ,Drug Administration ,Nasdaq ,Palisade Bio Inc ,Fast Track ,Medical Officer ,Palisade Bio ,Accelerated Approval ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,Nasdaq Pali ,Nc ,Clinical Stage ,Iopharmaceutical Company ,Fast Track Designation ,Fda ,B1148 ,Ai Surgery ,